Epitope optimization for heterologous prime-boost HIV vaccines
Epitope optimization for heterologous prime-boost HIV vaccines
批准号:
9138212
负责人:
TIMOTHY J CARDOZO
金额:
$25.43万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2018-03-31
关键词:
AIDS/HIV problemAcquired Immunodeficiency SyndromeAffectAntibodiesAntibody FormationAntigensB-Lymphocyte EpitopesBindingCD8B1 geneCharacteristicsCodon NucleotidesCommunitiesComplexDNADNA SequenceEpitopesFoundationsGeneticGlycoproteinsGoalsHIVHIV Envelope Protein gp120HIV InfectionsHIV vaccineHumanImmune responseImmunizationIndividualLinkMolecularMolecular ConformationMonoclonal AntibodiesNeutralization TestsOryctolagus cuniculusOutcomePhysiologicalPlasmaProteinsProtocols documentationQuantitative Structure-Activity RelationshipReagentResearchResearch Project GrantsSerumSourceStructure-Activity RelationshipSurfaceSystemTechnologyTestingUnited States National Institutes of HealthUrsidae FamilyV3 LoopVaccine Clinical TrialVaccine DesignVaccinesbasedesignenv Geneshigh rewardhigh riskhuman subjectimmunogenicimprovedinnovationinterestnovelpolyclonal antibodyprogramspublic health relevanceresearch studyresistant strainresponsethree dimensional structurevaccine trialvector
中文摘要
英文摘要
DESCRIPTION (provided by applicant): As a result of the RV144 trial and numerous recent studies, heterologous prime-boost HIV vaccine strategies have emerged as the leading approach to elicit immune responses that could protect against HIV infection. The molecular basis of the heterologous approach over homologous approaches is not well understood, however. In particular, immune responses to vector or DNA priming immunizations that are then amplified by protein boost immunization are complex and obscure. In this proposal, we will perform experiments that may clarify unsuspected, fundamental aspects of the immune responses to the prime that are amplified by the protein boost. To test this, we will control for many factors in a heterologous prime-boost experiment, varying only the conformational B-cell epitopes between prime and boost. Our innovative hypothesis is that the conformation of B-cell epitopes in the prime influences those self-same epitopes in the boost. Rabbits will be immunized with an array of DNA primes constructed to express or exclude specific immunogenic HIV variable loop epitopes and then boosted with an immunofocused protein immunogen that exclusively bears those epitopes. We expect to observe whether the expression of a conformational epitope in the prime amplifies or retards elicitation of neutralizin antibodies from that self-same epitope provided on the protein boost. The results will clearly provide the first consistent rationale for selecting or designing HIV env genes for use in priming immunizations. This exploratory R21 project will thus form the foundation for a unique long-term research program into the molecular details of the interaction between priming and boosting immunizations in a heterologous prime-boost strategy. These details may be crucial for designing an efficacious HIV vaccine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery of novel openers of the understudied human drug target Kir6.1
-
批准号:10580933
-
项目类别:
-
资助金额:$46.61万
-
财政年份:2022
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
ADE-minimized COVID-19 vaccine via epitope focusing and anti-inflammatory innate immunity
-
批准号:10161068
-
项目类别:
-
资助金额:$46.61万
-
财政年份:2020
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer
-
批准号:8698061
-
项目类别:
-
资助金额:$63.97万
-
财政年份:2014
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer
-
批准号:9263411
-
项目类别:
-
资助金额:$7.94万
-
财政年份:2014
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer
-
批准号:9379050
-
项目类别:
-
资助金额:$6.05万
-
财政年份:2014
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Structure Based Characterization of gp120 Non-V3 Variable Loop Epitopes
-
批准号:8733248
-
项目类别:
-
资助金额:$62.36万
-
财政年份:2014
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer
-
批准号:9094005
-
项目类别:
-
资助金额:$7.94万
-
财政年份:2014
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Combined cocaine and HIV vaccine
-
批准号:8606078
-
项目类别:
-
资助金额:$84.75万
-
财政年份:2013
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Combined cocaine and HIV vaccine
-
批准号:8727501
-
项目类别:
-
资助金额:$84.75万
-
财政年份:2013
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Combined cocaine and HIV vaccine
-
批准号:8884699
-
项目类别:
-
资助金额:$6.53万
-
财政年份:2013
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Combined cocaine and HIV vaccine
-
批准号:9481884
-
项目类别:
-
资助金额:$1.93万
-
财政年份:2013
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Combined cocaine and HIV vaccine
-
批准号:9274942
-
项目类别:
-
资助金额:$84.75万
-
财政年份:2013
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Combined cocaine and HIV vaccine
-
批准号:9331777
-
项目类别:
-
资助金额:$27.11万
-
财政年份:2013
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Combined cocaine and HIV vaccine
-
批准号:9068553
-
项目类别:
-
资助金额:$0.98万
-
财政年份:2013
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Combined cocaine and HIV vaccine
-
批准号:9307253
-
项目类别:
-
资助金额:$4.07万
-
财政年份:2013
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
A Chemical Biology Network for Personalized Medicine
-
批准号:7855454
-
项目类别:
-
资助金额:$209.39万
-
财政年份:2010
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Structure-Based Characterization of gp120 Non-V3 Variable Loop Epitopes
-
批准号:8321530
-
项目类别:
-
资助金额:$75.98万
-
财政年份:2009
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Structure-Based Characterization of gp120 Non-V3 Variable Loop Epitopes
-
批准号:7737804
-
项目类别:
-
资助金额:$62.59万
-
财政年份:2009
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Structure-Based Characterization of gp120 Non-V3 Variable Loop Epitopes
-
批准号:8121572
-
项目类别:
-
资助金额:$58.57万
-
财政年份:2009
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
Structure-Based Characterization of gp120 Non-V3 Variable Loop Epitopes
-
批准号:7928943
-
项目类别:
-
资助金额:$60.25万
-
财政年份:2009
-
负责人:TIMOTHY J CARDOZO
-
依托单位:
海外基金